Pfizer STN 37.5 mg Pill - yellow capsule/oblong, 16mm
Generic Name: sunitinib
Pill with imprint Pfizer STN 37.5 mg is Yellow, Capsule/Oblong and has been identified as Sutent 37.5 mg. It is supplied by Pfizer U.S. Pharmaceuticals Group.
Sutent is used in the treatment of Renal Cell Carcinoma; Pancreatic Cancer; Gastrointestinal Stromal Tumor and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sutent 37.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Pfizer STN 37.5 mg
Sutent
- Generic Name
- sunitinib
- Imprint
- Pfizer STN 37.5 mg
- Strength
- 37.5 mg
- Color
- Yellow
- Size
- 16.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors, VEGF/VEGFR inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer U.S. Pharmaceuticals Group
- National Drug Code (NDC)
- 00069-0830
- Inactive Ingredients
-
mannitol,
croscarmellose sodium,
povidone k25,
magnesium stearate,
titanium dioxide,
ferric oxide red,
ferric oxide yellow,
ferrosoferric oxide,
shellac,
propylene glycol,
sodium hydroxide,
potassium hydroxide
Note: Inactive ingredients may vary.
More about Sutent (sunitinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (30)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
